The new service, Trial Insights, is a digital reporting solution, which collates data every night from publicly-available data sources such as ClinicalTrials.gov.
“The Trial Insights reporting dashboard is intended for those on the edge of evaluating an acquisition, looking for investigators to run their trial, wanting to keep tabs on competitors, as well as looking for trends in what is ‘hot’ and what is ‘not’ in drugs, targets, and biomarkers,” said Mark Herbert, chief business officer (CBO), Scientist.com.
“Trial Insights bridges the gap between integrated enterprise solutions, public databases, and mass export economy reports,” he told us.
Herbert said subscribers to the new service can scan for trends, avoid underperforming sites, identify new opportunities, access investigator heat maps, biomarker data, and more. This tailored data, delivered in real-time, can be shared to help users make better-informed decisions, he added.
“Trial Insights limits dead ends and unexpected surprises quickly and efficiently, so there are no wasted budgets,” Herbert said.